— Know what they know.
Not Investment Advice

KOD NASDAQ

Kodiak Sciences Inc.
1W: -3.3% 1M: -17.2% 3M: +48.0% YTD: +43.8% 1Y: +821.4% 3Y: +542.8% 5Y: +122.5%
$36.23
-1.18 (-3.15%)
 
Weekly Expected Move ±7.2%
$32 $34 $37 $40 $42
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 30 · $1.9B mcap · 49M float · 2.19% daily turnover · Short 76% of daily vol

Cash Flow Trends

Operating Cash Flow
-$117M +23.9% ▲
Capital Expenditures
$400K +99.0% ▲
5Y CAGR: -1.8%
Free Cash Flow
-$118M +39.8% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$118M -223.7% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$133M-$267M-$334M-$260M-$176M
Depreciation & Amort.$4M$9M$11M$26M$27M
Stock-Based Comp.$31M$61M$0$89M$60M
Change in Working Capital$15M$14M$12M-$7M-$28M
Other Non-Cash Items$49K$198K$104M-$840K$355K
Operating Cash Flow-$83M-$182M-$206M-$154M-$117M
— Investing Activities —
Capital Expenditures-$7M-$63M-$47M-$41M-$400K
Acquisitions (Net)$3M$0$0-$291K$0
Investment Purchases-$86M$0-$428M-$49M-$355K
Investment Sales$198M$24M$138M$340M$0
Other Investing-$3M$0$616K$291K$0
Investing Cash Flow$105M-$39M-$337M$249M-$755K
— Financing Activities —
Net Debt Issuance-$5K$0$0$0$0
Stock Repurchased-$487K$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$106M$8M-$49K-$211K$0
Financing Cash Flow$717M$8M$2M$31K$501K
Net Change in Cash$739M-$213M-$541M$95M-$118M
Cash End of Period$951M$738M$190M$286M$174M
Free Cash Flow-$90M-$246M-$254M-$196M-$118M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms